The DIFC Court of First Instance issued a formal consent order resolving an application for an interim injunction, establishing binding restrictive covenants and confidentiality obligations upon Dr. Kamal Akkach in the context of a healthcare sector shareholder dispute.
What are the core commercial stakes and the nature of the dispute between Health Bay Investment and Dr. Kamal Akkach in CFI 087/2019?
The lawsuit involves a commercial dispute between the Claimants, Health Bay Investment in Healthcare Enterprises & Development LLC and Anglo Arabian Healthcare Investments LLC, and the Defendant, Dr. Kamal Akkach. The litigation centers on the enforcement of obligations arising from a Shareholders’ Agreement. The Claimants sought an interim injunction to restrain the Defendant from engaging in activities that would allegedly breach his contractual duties, specifically regarding the solicitation of customers and employees, and the protection of confidential corporate information.
The stakes involve the operational integrity of the Claimants’ healthcare business. By entering into this consent order, the parties effectively paused the litigation process regarding the injunction, opting instead for a court-sanctioned framework of restrictive covenants. The order serves to protect the Claimants' commercial interests while acknowledging the Defendant's ongoing professional obligations. As noted in the order:
The Defendant must not do it through others acting on the Defendant’s behalf or on the Defendant’s instructions or with the Defendant’s encouragement.
This provision ensures that the prohibitions on solicitation and dealing are not circumvented through third-party intermediaries, thereby securing the Claimants' market position during the pendency of the underlying proceedings.
Which DIFC Court judge presided over the consent order in CFI 087/2019?
The consent order was issued by Nour Hineidi, sitting in the DIFC Court of First Instance, on 26 February 2020. The order was processed following the Claimants' application for an interim injunction dated 12 December 2019, which had been scheduled for a hearing on 9 March 2020 before the court vacated that date in favor of the agreed-upon terms.
How did the parties, represented by Pinsent Masons LLP, structure their legal positions regarding the interim injunction?
The Claimants, Health Bay Investment and Anglo Arabian Healthcare Investments, moved for an interim injunction to prevent the Defendant from competing or soliciting within the UAE healthcare market. Their position was predicated on the enforcement of restrictive covenants contained within the Shareholders’ Agreement. Conversely, Dr. Kamal Akkach, represented by Pinsent Masons LLP, consented to the order while explicitly preserving his right to challenge the enforceability of the underlying Shareholders’ Agreement in future proceedings.
This "without prejudice" stance allowed the Defendant to mitigate the immediate risk of an injunction while reserving his substantive defense. The agreement reflects a strategic compromise where the Defendant accepted specific conduct restrictions in exchange for the vacation of the 9 March 2020 hearing, while the Claimants secured immediate protection of their business interests without the uncertainty of a contested hearing.
What was the precise jurisdictional and doctrinal question the DIFC Court addressed in this consent order?
The court was tasked with determining whether to grant an interim injunction based on the contractual obligations of a shareholder-physician. The doctrinal issue involved balancing the enforceability of restrictive covenants in a commercial contract against the professional and ethical duties of a medical practitioner. The court had to ensure that the order provided the Claimants with sufficient protection against unfair competition while simultaneously incorporating "carve-outs" that prevented the order from interfering with the Defendant’s medical practice.
How did the court balance the restrictive covenants against the Defendant’s professional obligations as a physician?
The court utilized a specific "carve-out" mechanism to ensure that the injunction did not impede the Defendant’s ability to provide essential medical care. The reasoning was structured to prioritize the physician's ethical obligations over the commercial restrictive covenants. The order explicitly states:
For the avoidance of doubt, nothing in this Order shall prevent the Defendant from providing medical care, treatment or services of whatever kind to any person where to refuse provision of such medical care, treatment or services would cause the Defendant to breach his professional, ethical or other similar obligations as a physician in any jurisdiction.
To maintain transparency, the court required the Defendant to notify the Claimants if he relied on this exception. However, the court respected patient privacy by stipulating that:
The Defendant shall not be required to identify the relevant patient or the medical care, treatment or service provided.
This reasoning demonstrates a sophisticated approach to balancing commercial contract law with the public interest in medical care, ensuring that the court’s intervention did not result in a breach of the Defendant’s professional duties.
Which specific legal authorities and procedural rules were invoked to formalize the agreement between the parties?
The order was issued under the procedural framework of the DIFC Courts, specifically utilizing the court’s power to grant interim injunctions to preserve the status quo until trial. The order references the Claimants' application notice dated 12 December 2019 and the underlying Shareholders’ Agreement as the source of the substantive obligations. Furthermore, the order incorporates standard DIFC Court procedural safeguards, including the "Penal Notice" warning regarding contempt of court for non-compliance, which is a standard feature of injunctions issued under the Rules of the DIFC Courts (RDC).
How did the court address the potential for future legal disclosures and the protection of confidential information?
The court provided clear guidance on the scope of confidentiality, ensuring that the Defendant could still function in a legal capacity. The order includes a specific provision for legal proceedings:
For the avoidance of doubt nothing in this Order shall prevent the Defendant from disclosing any Confidential Information to his properly instructed legal representatives for the purposes of conducting any legal proceedings in which he and the First Claimant or the Second Claimant are a party.
This ensures that the injunction does not hinder the Defendant’s right to legal counsel or his ability to defend himself in the ongoing litigation. The order also provides a mechanism for the Claimants to compensate the Defendant should the court later determine that the injunction caused him loss, as stated in the undertaking:
The First Claimant and Second Claimant undertake that if the DIFC Court later finds that that this Order has caused loss to the Defendant, and decides that the Defendant should be compensated for that loss, the First Claimant and Second Claimant will comply with any Order the DIFC Court may make.
What was the final disposition and the specific relief granted to the Claimants?
The court granted the consent order, which resulted in the immediate vacation of the 9 March 2020 hearing. The relief granted to the Claimants includes:
1. A prohibition on the Defendant from soliciting or approaching "Relevant Customers" for the sale of "Relevant Products or Services" in the UAE.
2. A prohibition on the Defendant from dealing or contracting with such customers.
3. A prohibition on the solicitation or recruitment of the Claimants' employees.
4. A strict confidentiality requirement regarding the Claimants' business affairs.
The order also established a notification protocol for the Defendant if he provides medical services that would otherwise breach the restrictive covenants, and it designated the service of the order on Pinsent Masons LLP as the official method of notification. Costs were reserved for a later determination.
What are the wider implications for practitioners handling restrictive covenants in the DIFC healthcare sector?
This case highlights the necessity of drafting "carve-outs" when dealing with professional services, particularly in the medical field. Practitioners must anticipate that the DIFC Court will not enforce restrictive covenants in a manner that forces a physician to breach their ethical or professional obligations. The inclusion of a "liberty to apply" clause, as noted below, ensures that the parties can return to the court if the balance between commercial protection and professional duty shifts:
The First Claimant, the Second Claimant and the Defendant each shall have liberty to apply to the DIFC Court generally in relation to this Order.
Litigants should also note the court’s willingness to accept "without prejudice" consent orders, which allow parties to settle interim disputes without conceding the ultimate merits of the case. This provides a roadmap for resolving high-stakes injunction applications through negotiation rather than protracted court hearings.
Where can I read the full judgment in Health Bay Investment v Dr Kamal Akkach [2020] DIFC CFI 087?
The full text of the consent order can be accessed via the DIFC Courts website: https://www.difccourts.ae/rules-decisions/judgments-orders/court-first-instance/cfi-0872019-1-health-bay-investment-healthcare-enterprises-development-llc-2-anglo-arabian-healthcare-investments-llc-v-dr-kamal or via the CDN link: https://littdb.sfo2.cdn.digitaloceanspaces.com/litt/AE/DIFC/judgments/court-first-instance/DIFC_CFI-087-2019_20200226.txt.
Cases referred to in this judgment:
(None cited in the text of the order)
Legislation referenced:
- Rules of the DIFC Courts (RDC)
- Shareholders’ Agreement (as referenced in the order)